Navamedic ASA: Enters into partnership agreement for distribution of Zorflex® in Sweden and Finland
December 21, 2017 02:46 ET
|
Navamedic
Oslo, December 22, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into an agreement with Chemviron Carbon Ltd. (Chemviron)...
Navamedic ASA: Enters into long-term agreement for distribution of GoNitro®* in the Nordics
November 20, 2017 02:01 ET
|
Navamedic
Oslo, November 20, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a preliminary long-term agreement with G....
Navamedic ASA: Resultater for tredje kvartal 2017
November 10, 2017 01:01 ET
|
Navamedic
Oslo, 10. november 2017 - Navamedic ASA (OSE: NAVA), rapporterte driftsinntekter på NOK 44,9 millioner i tredje kvartal 2017, ned fra NOK 65,2 millioner i samme periode i fjor, etter det planlagte...
Navamedic ASA: Q3 2017 results
November 10, 2017 01:01 ET
|
Navamedic
Oslo, November 10, 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 44.9 million in the third quarter of 2017, down from NOK 65.2 million in the same period in 2016, following the planned...
Navamedic ASA: Invitation to presentation of third quarter results 2017
November 02, 2017 05:22 ET
|
Navamedic
Navamedic ASA invites you to a presentation of the third quarter 2017 figures. The presentation takes place at Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Friday 10 November. The...
Navamedic ASA: Invitation to presentation of third quarter results 2017
November 02, 2017 04:50 ET
|
Navamedic
Navamedic ASA invites you to follow an online presentation of the third quarter2017 figures.The presentation will be webcasted at www.navamedic.com - investor relations -presentations - webcast on...
Navamedic ASA: Trade by primary insider
August 25, 2017 02:01 ET
|
Navamedic
Kathryn Baker, Chairman of the Board in Navamedic ASA has of 24 August 2017 acquired 3400 shares in Navamedic ASA. The shares are acquired through her company Lakeside AS at an average price...
Navamedic ASA: Enters into partnership agreement for distribution of ELMIRON® in the Nordics
August 21, 2017 02:01 ET
|
Navamedic
Oslo, August 21, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a long term agreement with bene-Arznemittel GmbH...
Navamedic ASA: Resultater for annet kvartal 2017
July 28, 2017 01:02 ET
|
Navamedic
Oslo, 28. juli 2017 - Navamedic ASA (OSE: NAVA), rapporterte driftsinntekter på NOK 89,7 millioner i andre kvartal 2017 (NOK 66,7 millioner i Q2 2016), tilsvarende en vekst på 34,4%, hovedsakelig som...
Navamedic ASA: Second quarter results 2017
July 28, 2017 01:02 ET
|
Navamedic
Oslo, 28 July 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 89.7 million in the second quarter of 2017 (NOK 66.7 million in Q2 2016), representing a growth of 34.4%, following the...